169 related articles for article (PubMed ID: 37799140)
1. Identification of key claudin genes associated with survival prognosis and diagnosis in colon cancer through integrated bioinformatic analysis.
Alghamdi RA; Al-Zahrani MH
Front Genet; 2023; 14():1221815. PubMed ID: 37799140
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Prognostic Relevance of Differential Claudin Gene Expression Highlights Claudin-4 as Being Suppressed by TGFβ1 Inhibitor in Colorectal Cancer.
Yang L; Zhang W; Li M; Dam J; Huang K; Wang Y; Qiu Z; Sun T; Chen P; Zhang Z; Zhang W
Front Genet; 2022; 13():783016. PubMed ID: 35281827
[No Abstract] [Full Text] [Related]
3. Identification of claudin-2, -6, -11 and -14 as prognostic markers in human breast carcinoma.
Jia H; Chai X; Li S; Wu D; Fan Z
Int J Clin Exp Pathol; 2019; 12(6):2195-2204. PubMed ID: 31934042
[TBL] [Abstract][Full Text] [Related]
4. Identification of claudin‑1, ‑3, ‑7 and ‑8 as prognostic markers in human laryngeal carcinoma.
Zhou S; Piao X; Wang C; Wang R; Song Z
Mol Med Rep; 2019 Jul; 20(1):393-400. PubMed ID: 31115553
[TBL] [Abstract][Full Text] [Related]
5. Claudin-6 and claudin-9 function as additional coreceptors for hepatitis C virus.
Zheng A; Yuan F; Li Y; Zhu F; Hou P; Li J; Song X; Ding M; Deng H
J Virol; 2007 Nov; 81(22):12465-71. PubMed ID: 17804490
[TBL] [Abstract][Full Text] [Related]
6. Claudins and Gastric Cancer: An Overview.
Hashimoto I; Oshima T
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053454
[TBL] [Abstract][Full Text] [Related]
7. The Expression of the Claudin Family of Proteins in Colorectal Cancer.
Cox KE; Liu S; Hoffman RM; Batra SK; Dhawan P; Bouvet M
Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540693
[TBL] [Abstract][Full Text] [Related]
8. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
[No Abstract] [Full Text] [Related]
9. Claudins and hepatocellular carcinoma.
Wang W; Zhou Y; Li W; Quan C; Li Y
Biomed Pharmacother; 2024 Feb; 171():116109. PubMed ID: 38185042
[TBL] [Abstract][Full Text] [Related]
10. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y
Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794
[TBL] [Abstract][Full Text] [Related]
11. Identification of DLL3-related genes affecting the prognosis of patients with colon adenocarcinoma.
Xiang J; Gong W; Liu J; Zhang H; Li M; Wang R; Lv Y; Sun P
Front Genet; 2023; 14():1098190. PubMed ID: 37274780
[No Abstract] [Full Text] [Related]
12. Claudin gene expression profiles and clinical value in colorectal tumors classified according to their molecular subtype.
Cherradi S; Martineau P; Gongora C; Del Rio M
Cancer Manag Res; 2019; 11():1337-1348. PubMed ID: 30863148
[TBL] [Abstract][Full Text] [Related]
13. Clinical Correlation of Wnt2 and COL8A1 With Colon Adenocarcinoma Prognosis.
Zhang L; Jiang X; Li Y; Fan Q; Li H; Jin L; Li L; Jin Y; Zhang T; Mao Y; Hua D
Front Oncol; 2020; 10():1504. PubMed ID: 32983993
[TBL] [Abstract][Full Text] [Related]
14. Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma.
Huang W; Liu Z; Li Y; Liu L; Mai G
J Cell Biochem; 2019 Mar; 120(3):4121-4131. PubMed ID: 30269368
[TBL] [Abstract][Full Text] [Related]
15. CLDN23 gene, frequently down-regulated in intestinal-type gastric cancer, is a novel member of CLAUDIN gene family.
Katoh M; Katoh M
Int J Mol Med; 2003 Jun; 11(6):683-9. PubMed ID: 12736707
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic values of integrin α subfamily mRNA expression in colon adenocarcinoma.
Gong YZ; Ruan GT; Liao XW; Wang XK; Liao C; Wang S; Gao F
Oncol Rep; 2019 Sep; 42(3):923-936. PubMed ID: 31322253
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-Related Gene-Based Signature Can Evaluate the Tumor Immune Microenvironment and Predict the Prognosis of Colon Adenocarcinoma Patients.
He X; Ding J; Cheng X; Xiong M
Int J Gen Med; 2021; 14():9853-9862. PubMed ID: 34938106
[TBL] [Abstract][Full Text] [Related]
18. An epithelial-mesenchymal transition-related mRNA signature associated with the prognosis, immune infiltration and therapeutic response of colon adenocarcinoma.
Zhang Y; Li Y; Zuo Z; Li T; An Y; Zhang W
Pathol Oncol Res; 2023; 29():1611016. PubMed ID: 36910014
[No Abstract] [Full Text] [Related]
19. Weighted Gene Co-expression Network Analysis Identified a Novel Thirteen-Gene Signature Associated With Progression, Prognosis, and Immune Microenvironment of Colon Adenocarcinoma Patients.
Zhang C; Zhao Z; Liu H; Yao S; Zhao D
Front Genet; 2021; 12():657658. PubMed ID: 34322151
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel glycolysis-related gene signature for predicting the survival of patients with colon adenocarcinoma.
Yi K; Wu J; Tang X; Zhang Q; Wang B; Wang F
Scand J Gastroenterol; 2022 Feb; 57(2):214-221. PubMed ID: 34644216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
